Individual Treatment Effects and Randomized Controlled Trials
David M. Kent, MD, MSc, associate professor of Medicine, Neurology, and Clinical and Translational Science at Tufts Medical Center, describes the limitations of randomized control trials in identifying individual treatment effects. To offset these limitations, he recommends researchers routinely risk stratify their trial populations since risk modeling is a fundamental determinant of the opportunity for treatment benefit. We spoke with Dr. Kent during \"The Myth of Average: Why Individual Patient Differences Matter,\" a conference focusing on issues related to individual treatment effects.From:npcnowViews:0 0ratingsTime:02:05More inScience Technology
<\/p>\n
Excerpt from: Individual Treatment Effects and Randomized Controlled Trials David M. Kent, MD, MSc, associate professor of Medicine, Neurology, and Clinical and Translational Science at Tufts Medical Center, describes the limitations of randomized control trials in identifying individual treatment effects Continue reading
\nIndividual Treatment Effects and Randomized Controlled Trials - Video<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"